Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 5/20 | 0.71 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.71 |
| ▸ | TYR | P14679 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | IL2 | P60568 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14120677 | 0.91 | TYR (0.66) | SLC5A2SLC5A1TYRNPC1RAB9A | |
| SCHEMBL29366475 | 0.87 | TYR (0.69) | SLC5A2SLC5A1TYRNPC1RAB9A | |
| SCHEMBL23479758 | 0.86 | TYR (0.62) | SLC5A2SLC5A1TYR | |
| SCHEMBL14120978 | 0.86 | TYR (0.62) | SLC5A2SLC5A1TYR | |
| SCHEMBL9100644 | 0.86 | TYR (0.62) | SLC5A2SLC5A1TYR | |
| SCHEMBL5506137 | 0.86 | TYR (0.62) | SLC5A2SLC5A1TYR | |
| SCHEMBL7031808 | 0.85 | SLC28A3 (0.58) | SLC5A2SLC5A1TYR | |
| SCHEMBL28720265 | 0.85 | SLC5A1 (0.61) | SLC5A2SLC5A1TYRNPC1RAB9A | |
| SCHEMBL8388035 | 0.85 | TYR (0.75) | SLC5A2SLC5A1TYRNPC1RAB9A | |
| SCHEMBL7744552 | 0.85 | TYR (0.75) | SLC5A2SLC5A1TYRNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113980071-B | Rhodiola rosea glycoside derivative and application thereof | 重庆大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-113980071-A | Salidroside derivatives and application thereof | 重庆大学 | 2022-01-28 | — | — | CN | disclosed |